van de Locht L - Search Results

1

Expression of C-IAP1, C-IAP2 and SURVIVIN discriminates different types of lymphoid malignancies.

de Graaf AO, van Krieken JH, Tönnissen E, Wissink W, van de Locht L, Overes I, Dolstra H, de Witte T, van der Reijden BA, Jansen JH. de Graaf AO, et al. Among authors: van de locht l. Br J Haematol. 2005 Sep;130(6):852-9. doi: 10.1111/j.1365-2141.2005.05690.x. Br J Haematol. 2005. PMID: 16156855 Free article.

2

Abnormal WT1 expression in the CD34-negative compartment in myelodysplastic bone marrow.

Van Dijk JP, Knops GH, Van De Locht LT, Menke AL, Jansen JH, Mensink EJ, Raymakers RA, De Witte T. Van Dijk JP, et al. Among authors: van de locht lt, de witte t. Br J Haematol. 2002 Sep;118(4):1027-33. doi: 10.1046/j.1365-2141.2002.03728.x. Br J Haematol. 2002. PMID: 12199781 Free article.

3

An antisense Bcr-Abl phosphodiester-tailed methylphosphonate oligonucleotide reduces the growth of chronic myeloid leukaemia patient cells by a non-antisense mechanism.

Smetsers TF, Linders EH, van de Locht LT, de Witte TM, Mensink EJ. Smetsers TF, et al. Among authors: van de locht lt, de witte tm. Br J Haematol. 1997 Feb;96(2):377-81. doi: 10.1046/j.1365-2141.1997.d01-2035.x. Br J Haematol. 1997. PMID: 9029029 Free article.

4

Degradable dU-based DNA template as a standard in real-time PCR quantitation.

Pennings JL, Van De Locht LT, Jansen JH, Van der Reijden BA, De Witte T, Mensink EJ. Pennings JL, et al. Among authors: van de locht lt, van der reijden ba, de witte t. Leukemia. 2001 Dec;15(12):1962-5. doi: 10.1038/sj.leu.2402290. Leukemia. 2001. PMID: 11753618

5

Rapid identification of IDH1 and IDH2 mutations in acute myeloid leukaemia using high resolution melting curve analysis.

Noordermeer SM, Tönnissen E, Vissers I, van der Heijden A, van de Locht LT, Deutz-Terlouw PP, Marijt EW, Jansen JH, van der Reijden BA. Noordermeer SM, et al. Among authors: van de locht lt. Br J Haematol. 2011 Feb;152(4):493-6. doi: 10.1111/j.1365-2141.2010.08423.x. Epub 2010 Oct 19. Br J Haematol. 2011. PMID: 20955413 Free article. No abstract available.

6

Clonal evolution in myelodysplastic syndromes.

da Silva-Coelho P, Kroeze LI, Yoshida K, Koorenhof-Scheele TN, Knops R, van de Locht LT, de Graaf AO, Massop M, Sandmann S, Dugas M, Stevens-Kroef MJ, Cermak J, Shiraishi Y, Chiba K, Tanaka H, Miyano S, de Witte T, Blijlevens NMA, Muus P, Huls G, van der Reijden BA, Ogawa S, Jansen JH. da Silva-Coelho P, et al. Among authors: van de locht lt. Nat Commun. 2017 Apr 21;8:15099. doi: 10.1038/ncomms15099. Nat Commun. 2017. PMID: 28429724 Free PMC article.

7

A low but functionally significant MDR1 expression protects primitive haemopoietic progenitor cells from anthracycline toxicity.

Smeets M, Raymakers R, Vierwinden G, Pennings A, van de Locht L, Wessels H, Boezeman J, de Witte T. Smeets M, et al. Among authors: van de locht l, de witte t. Br J Haematol. 1997 Feb;96(2):346-55. doi: 10.1046/j.1365-2141.1997.d01-2024.x. Br J Haematol. 1997. PMID: 9029024 Free article.

8

Clinical and biological impact of TET2 mutations and expression in younger adult AML patients treated within the EORTC/GIMEMA AML-12 clinical trial.

Aslanyan MG, Kroeze LI, Langemeijer SM, Koorenhof-Scheele TN, Massop M, van Hoogen P, Stevens-Linders E, van de Locht LT, Tönnissen E, van der Heijden A, da Silva-Coelho P, Cilloni D, Saglio G, Marie JP, Tang R, Labar B, Amadori S, Muus P, Willemze R, Marijt EW, de Witte T, van der Reijden BA, Suciu S, Jansen JH. Aslanyan MG, et al. Among authors: van de locht lt. Ann Hematol. 2014 Aug;93(8):1401-12. doi: 10.1007/s00277-014-2055-7. Epub 2014 Mar 29. Ann Hematol. 2014. PMID: 24994606

9

Rapid identification of CBFB-MYH11-positive acute myeloid leukemia (AML) cases by one single MYH11 real-time RT-PCR.

van der Reijden BA, Massop M, Tönnissen E, van de Locht L, Muus P, de Witte T, Jansen JH. van der Reijden BA, et al. Among authors: van de locht l, de witte t. Blood. 2003 Jun 15;101(12):5085-6. doi: 10.1182/blood-2003-02-0405. Blood. 2003. PMID: 12788791 Free article. No abstract available.

10

Biodistribution and retention time of retrovirally labeled T lymphocytes in mice is strongly influenced by the culture period before infusion.

Kolen S, Dolstra H, van de Locht L, Braakman E, Schattenberg A, de Witte T, van de Wiel-van Kemenade E. Kolen S, et al. Among authors: van de locht l, van de wiel van kemenade e, de witte t. J Immunother. 2002 Sep-Oct;25(5):385-95. doi: 10.1097/00002371-200209000-00002. J Immunother. 2002. PMID: 12218776

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page